Compare ENVA & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENVA | MMED |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.3B |
| IPO Year | 2011 | 2026 |
| Metric | ENVA | MMED |
|---|---|---|
| Price | $235.95 | $16.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $185.71 | $22.56 |
| AVG Volume (30 Days) | 382.4K | ★ 1.2M |
| Earning Date | 04-23-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.05 | N/A |
| EPS | ★ 7.45 | N/A |
| Revenue | ★ $3,151,653,000.00 | N/A |
| Revenue This Year | $149.64 | $15.99 |
| Revenue Next Year | $16.42 | $10.00 |
| P/E Ratio | $62.95 | ★ N/A |
| Revenue Growth | ★ 18.58 | N/A |
| 52 Week Low | $99.61 | $10.65 |
| 52 Week High | $246.38 | $17.86 |
| Indicator | ENVA | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 61.43 | 63.33 |
| Support Level | $220.13 | $14.70 |
| Resistance Level | $246.38 | N/A |
| Average True Range (ATR) | 8.73 | 0.90 |
| MACD | -3.01 | 0.04 |
| Stochastic Oscillator | 78.13 | 73.31 |
Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.